Hsiao CD, Wu HH, Malhotra N, Liu YC, Wu YH, Lin YN
About TRIUMPH-4 and the TRIUMPH clinical trial program TRIUMPH-4 (NCT05869903) is a Phase 3, 68-week, randomized, double-blind, placebo-controlled study comparing the efficacy and safety of retatrutide with placebo in adults with obesity or overweight and knee osteoarthritis
Acute Exposure to Blood Containing HBsAg(16) Table 1 summarizes prophylaxis for percutaneous (needlestick or bite), ocular, or mucous-membrane exposure to blood according to the source of exposure and vaccination status of the exposed person
By enhancing these processes, it provides an effective solution for managing type 2 diabetes and achieving significant weight loss
This helps people feel satisfied longer and significantly decreases the urge to feel hungry between meals
Grollman, A